A new formulation of ciprofloxacin with retarded release in therapy of patients with bronchopulmonary diseases
Adzhimuradova, D.K.; Sokolova, V.I.; Smirnova, L.B.; Orlov, V.A.
Antibiotiki i Khimioterapiia 51(9-10): 24-32
2006
ISSN/ISBN: 0235-2990 PMID: 18030788 Document Number: 595749
Document emailed within 1 workday
Related Documents
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350Bogner, R.H.; Szweijkowski, J.; Houston, A. 2001: Release of morphine sulfate from compounded slow-release capsules: the effect of formulation on release International Journal of Pharmaceutical Compounding 5(5): 401-405
Duvoisin, R.C. 1989: New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation Neurology 39(11 Suppl 2: 4-6
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
O'Connor, T.P.; Anderson, A.M.; Lennox, B.; Muldoon, C. 1993: A novel sustained-release formulation of ibuprofen provides effective once-daily therapy in the treatment of rheumatoid arthritis and osteoarthritis British Journal of Clinical Practice 47(1): 10-13
Hertle, F.H. 1983: Physical therapy in bronchopulmonary diseases Praxis und Klinik der Pneumologie 37(Suppl 1): 947-953
Wahab, A.; Khan, G.M.; Akhlaq, M.; Khan, N.R.; Hussain, A.; Khan, M.F.; Khan, H. 2011: Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism Die Pharmazie 66(9): 677-683
Franc, Aš.; Dvořáčková, Křina.; Muselík, J.; Zvaková, M.; Slováková, Víra.; Vetchý, D.; Sabadková, D.; Neumann, D.; Goněc, R. 2014: Formulation of cores for the controlled release of glucose for prevention of hypoglycemia in diabetes patients Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 63(5): 206-212
Zemskov, A.M.; Provotorov, V.M.; Nikitin, A.V.; Zemskov, V.M. 1984: Comparative effectiveness of immunomodulators in the therapy of bronchopulmonary diseases Antibiotiki 29(9): 673-676
Leupold, W. 1983: Medical care and therapy of chronic bronchopulmonary diseases in childhood Zeitschrift für Arztliche Fortbildung 77(14): 592-597
Arzubova, N.N. 1973: Inhalation procedures in outpatient therapy for children with bronchopulmonary diseases Meditsinskaia Sestra 32(5): 38-40
Dietzsch, H.J.; Thal, W.; Weingärtner, L. 1977: Recommendations for antibacterial therapy of chronic and recurring bronchopulmonary diseases Kinderarztliche Praxis 45(5): 234-236
Linares Borges, A.; Rodríguez Muñiz, J.M.; Alemán Aguilar, H.; Yamir Betancourt, B.; Jiménez Hernández, L.; Chala Tandrón, J.M.; Martín García, L.M.; de la Vega Elías, L. 2000: Clinical effect of a sustained-release theophylline formulation in moderate or severe asthmatic patients with intercrisis Revista Alergia Mexico 47(2): 65-69
Osin, A.Ia. 1988: Errors and rules in the practice of the aerosol therapy of bronchopulmonary diseases in children Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1988(6): 62-64
Usami, M.; Kotake, T.; Matsuda, M.; Okajima, E.; Osafune, M.; Sonoda, T. 1987: Clinical effect of slow release (depot) formulation of the LH-RH analogue ICi 118630 (Zoladex) in patients with prostatic carcinoma Hinyokika Kiyo. Acta Urologica Japonica 33(1): 141-150
Woodroffe, R. 1976: Formulation studies on slow-release phosphate tablets for high-dosage administration in renal transplant patients Journal of Pharmacy and Pharmacology 28 Suppl: 68p
Cleophas, T.J.; Niemeyer, M.G.; Zwinderman, A.H.; van der Wall, E.E. 2000: Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group Angiology 51(8): 631-638
Kongkanand, A.; Chodchoy, V.; Lojanapiwat, B.; Pumpaisanchai, S.; Ratana-Olarn, K.; Sae-Tang, P.; Taweemonkongsap, T. 2009: Safety and efficacy of a prolonged-release formulation of alfuzosin 10 mg once daily in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia Journal of the Medical Association of Thailand 92(7): 969-978
Kliachkin, L.M.; Shchegol'kov, A.M.; Bulavin, V.V.; Proskurin, V.M. 1990: Status of microcirculation in patients with ischemic heart disease and concomitant bronchopulmonary diseases Klinicheskaia Meditsina 68(7): 75-78
Lebedeva, T.G.; Evsikova, N.A.; Pereshivkina, E.I.; Trofimova, E.V.; Rozno, A.I. 1971: Chronic non-specific bronchopulmonary diseases in tuberculosis patients and their treatment at health resorts Problemy Tuberkuleza 49(3): 23-26